Recent Updates
Recently added Catalysts
ELUT Positive Sentiment Score: 70/100

Elutia to Participate in Upcoming Investor Conferences

Thursday, April 3, 2025 1 min read
Key Takeaway: Elutia Inc. has announced its participation in two upcoming investor conferences, the LD Micro 15th Annual Invitational in New York and the Planet Microcap Showcase in Las Vegas. Company executives, including Dr. Randy Mills and Matt Ferguson, will present and engage in one-on-one meetings with institutional investors. Elutia aims to enhance compatibility of medical devices through its pioneering drug-eluting biomatrix technologies, emphasizing its commitment to improving patient outcomes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Elutia's leadership is participating in key investor conferences.
  • Focused on improving medical device compatibility for patients.
  • Shows proactive engagement with institutional investors.

Full Press Release Details

SILVER SPRING, Md., April 03, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences:
LD Micro 15th Annual Invitational – New York, NY
Format: Presentation and 1x1 Meetings
Presentation Date and Time: Thursday, April 10, 2025, 12:30 p.m. ET (9:30 a.m. PT)
Planet Microcap Showcase – Las Vegas, NV
Format: Presentation and 1x1 Meetings
Presentation Date and Time: Wednesday, April 23, 2025, 4:00 p.m. ET (1:00 p.m. PT)
Elutia management will also participate in 1x1 investor meetings. Institutional investors interested in scheduling a meeting may contact an LD Micro or Planet Microcap representative or email IR@elutia.com.
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
matt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.

Frequently Asked Questions

What are the upcoming investor conferences for Elutia?

Elutia will present at the LD Micro 15th Annual Invitational and the Planet Microcap Showcase.

Who will represent Elutia at these events?

Dr. Randy Mills and Matt Ferguson will represent Elutia at the conferences.

How can investors schedule meetings with Elutia's management?

Investors can contact LD Micro or Planet Microcap representatives or email IR@elutia.com.

What is the focus of Elutia's technology?

Elutia focuses on drug-eluting biomatrix products for better medical device compatibility.

What is Elutia's mission?

Elutia's mission is to humanize medicine, allowing patients to thrive without compromise.

Tags: ELUT Viatris Investor Conferences Healthcare Elutia drug-eluting biomatrix investor conferences LD Micro Planet Microcap
Last updated: Apr 3, 2025